Report Detail
Global Oncolytic Virus Manufacturing and Development Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4734672 |
- 24 August, 2026 |
- Global |
- 110 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global Oncolytic Virus Manufacturing and Development Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Oncolytic Virus Manufacturing and Development Services encompass the specialized processes involved in creating and optimizing viruses that selectively infect and destroy cancer cells. These services include the development of viral vectors, process optimization, large-scale production, purification, and quality control of oncolytic viruses. Additionally, they involve regulatory support, preclinical testing, and clinical trial manufacturing. The goal is to ensure that these viruses are produced safely and effectively for use in therapeutic applications, including cancer immunotherapy and combination treatments with other modalities.
This report is a detailed and comprehensive analysis for global Oncolytic Virus Manufacturing and Development Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncolytic Virus Manufacturing and Development Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Oncolytic Virus Manufacturing and Development Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Oncolytic Virus Manufacturing and Development Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Oncolytic Virus Manufacturing and Development Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncolytic Virus Manufacturing and Development Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncolytic Virus Manufacturing and Development Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, Creative Biolabs, Takara Bio, Libentech, ABL, Nabios, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncolytic Virus Manufacturing and Development Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oncolytic Herpes Simplex Virus
Oncolytic Adenovirus
Oncolytic Vaccinia Virus
Others
Market segment by Application
R&D
Biopharmaceutical Manufacturers
Others
Market segment by players, this report covers
Recipharm (Vibalogics)
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
Creative Biolabs
Takara Bio
Libentech
ABL
Nabios
Halix
Obio Technology
Porton Advanced
WuXi ATU
Genevoyager
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncolytic Virus Manufacturing and Development Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus Manufacturing and Development Services, with revenue, gross margin, and global market share of Oncolytic Virus Manufacturing and Development Services from 2021 to 2026.
Chapter 3, the Oncolytic Virus Manufacturing and Development Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Oncolytic Virus Manufacturing and Development Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus Manufacturing and Development Services.
Chapter 13, to describe Oncolytic Virus Manufacturing and Development Services research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Oncolytic Virus Manufacturing and Development Services by Type
- 1.3.1 Overview: Global Oncolytic Virus Manufacturing and Development Services Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Type in 2025
- 1.3.3 Oncolytic Herpes Simplex Virus
- 1.3.4 Oncolytic Adenovirus
- 1.3.5 Oncolytic Vaccinia Virus
- 1.3.6 Others
- 1.4 Global Oncolytic Virus Manufacturing and Development Services Market by Application
- 1.4.1 Overview: Global Oncolytic Virus Manufacturing and Development Services Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 R&D
- 1.4.3 Biopharmaceutical Manufacturers
- 1.4.4 Others
- 1.5 Global Oncolytic Virus Manufacturing and Development Services Market Size & Forecast
- 1.6 Global Oncolytic Virus Manufacturing and Development Services Market Size and Forecast by Region
- 1.6.1 Global Oncolytic Virus Manufacturing and Development Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Oncolytic Virus Manufacturing and Development Services Market Size by Region, (2021-2032)
- 1.6.3 North America Oncolytic Virus Manufacturing and Development Services Market Size and Prospect (2021-2032)
- 1.6.4 Europe Oncolytic Virus Manufacturing and Development Services Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size and Prospect (2021-2032)
- 1.6.6 South America Oncolytic Virus Manufacturing and Development Services Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Recipharm (Vibalogics)
- 2.1.1 Recipharm (Vibalogics) Details
- 2.1.2 Recipharm (Vibalogics) Major Business
- 2.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.1.4 Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Recipharm (Vibalogics) Recent Developments and Future Plans
- 2.2 IDT Biologika
- 2.2.1 IDT Biologika Details
- 2.2.2 IDT Biologika Major Business
- 2.2.3 IDT Biologika Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.2.4 IDT Biologika Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 IDT Biologika Recent Developments and Future Plans
- 2.3 FUJIFILM Diosynth Biotechnologies
- 2.3.1 FUJIFILM Diosynth Biotechnologies Details
- 2.3.2 FUJIFILM Diosynth Biotechnologies Major Business
- 2.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.3.4 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
- 2.4 Exothera
- 2.4.1 Exothera Details
- 2.4.2 Exothera Major Business
- 2.4.3 Exothera Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.4.4 Exothera Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Exothera Recent Developments and Future Plans
- 2.5 Lonza
- 2.5.1 Lonza Details
- 2.5.2 Lonza Major Business
- 2.5.3 Lonza Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.5.4 Lonza Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Lonza Recent Developments and Future Plans
- 2.6 Creative Biolabs
- 2.6.1 Creative Biolabs Details
- 2.6.2 Creative Biolabs Major Business
- 2.6.3 Creative Biolabs Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.6.4 Creative Biolabs Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Creative Biolabs Recent Developments and Future Plans
- 2.7 Takara Bio
- 2.7.1 Takara Bio Details
- 2.7.2 Takara Bio Major Business
- 2.7.3 Takara Bio Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.7.4 Takara Bio Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Takara Bio Recent Developments and Future Plans
- 2.8 Libentech
- 2.8.1 Libentech Details
- 2.8.2 Libentech Major Business
- 2.8.3 Libentech Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.8.4 Libentech Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Libentech Recent Developments and Future Plans
- 2.9 ABL
- 2.9.1 ABL Details
- 2.9.2 ABL Major Business
- 2.9.3 ABL Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.9.4 ABL Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 ABL Recent Developments and Future Plans
- 2.10 Nabios
- 2.10.1 Nabios Details
- 2.10.2 Nabios Major Business
- 2.10.3 Nabios Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.10.4 Nabios Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Nabios Recent Developments and Future Plans
- 2.11 Halix
- 2.11.1 Halix Details
- 2.11.2 Halix Major Business
- 2.11.3 Halix Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.11.4 Halix Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Halix Recent Developments and Future Plans
- 2.12 Obio Technology
- 2.12.1 Obio Technology Details
- 2.12.2 Obio Technology Major Business
- 2.12.3 Obio Technology Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.12.4 Obio Technology Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Obio Technology Recent Developments and Future Plans
- 2.13 Porton Advanced
- 2.13.1 Porton Advanced Details
- 2.13.2 Porton Advanced Major Business
- 2.13.3 Porton Advanced Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.13.4 Porton Advanced Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Porton Advanced Recent Developments and Future Plans
- 2.14 WuXi ATU
- 2.14.1 WuXi ATU Details
- 2.14.2 WuXi ATU Major Business
- 2.14.3 WuXi ATU Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.14.4 WuXi ATU Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 WuXi ATU Recent Developments and Future Plans
- 2.15 Genevoyager
- 2.15.1 Genevoyager Details
- 2.15.2 Genevoyager Major Business
- 2.15.3 Genevoyager Oncolytic Virus Manufacturing and Development Services Product and Solutions
- 2.15.4 Genevoyager Oncolytic Virus Manufacturing and Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Genevoyager Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Oncolytic Virus Manufacturing and Development Services Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Oncolytic Virus Manufacturing and Development Services by Company Revenue
- 3.2.2 Top 3 Oncolytic Virus Manufacturing and Development Services Players Market Share in 2025
- 3.2.3 Top 6 Oncolytic Virus Manufacturing and Development Services Players Market Share in 2025
- 3.3 Oncolytic Virus Manufacturing and Development Services Market: Overall Company Footprint Analysis
- 3.3.1 Oncolytic Virus Manufacturing and Development Services Market: Region Footprint
- 3.3.2 Oncolytic Virus Manufacturing and Development Services Market: Company Product Type Footprint
- 3.3.3 Oncolytic Virus Manufacturing and Development Services Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Oncolytic Virus Manufacturing and Development Services Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Oncolytic Virus Manufacturing and Development Services Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Oncolytic Virus Manufacturing and Development Services Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Oncolytic Virus Manufacturing and Development Services Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2032)
- 6.2 North America Oncolytic Virus Manufacturing and Development Services Market Size by Application (2021-2032)
- 6.3 North America Oncolytic Virus Manufacturing and Development Services Market Size by Country
- 6.3.1 North America Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2032)
- 6.3.2 United States Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 6.3.3 Canada Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2032)
- 7.2 Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2032)
- 7.3 Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country
- 7.3.1 Europe Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2032)
- 7.3.2 Germany Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 7.3.3 France Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 7.3.5 Russia Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 7.3.6 Italy Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region
- 8.3.1 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Consumption Value by Region (2021-2032)
- 8.3.2 China Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 8.3.3 Japan Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 8.3.5 India Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 8.3.7 Australia Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2032)
- 9.2 South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2032)
- 9.3 South America Oncolytic Virus Manufacturing and Development Services Market Size by Country
- 9.3.1 South America Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country
- 10.3.1 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
- 10.3.4 UAE Oncolytic Virus Manufacturing and Development Services Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Oncolytic Virus Manufacturing and Development Services Market Drivers
- 11.2 Oncolytic Virus Manufacturing and Development Services Market Restraints
- 11.3 Oncolytic Virus Manufacturing and Development Services Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Oncolytic Virus Manufacturing and Development Services Industry Chain
- 12.2 Oncolytic Virus Manufacturing and Development Services Upstream Analysis
- 12.3 Oncolytic Virus Manufacturing and Development Services Midstream Analysis
- 12.4 Oncolytic Virus Manufacturing and Development Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Oncolytic Virus Manufacturing and Development Services. Industry analysis & Market Report on Oncolytic Virus Manufacturing and Development Services is a syndicated market report, published as Global Oncolytic Virus Manufacturing and Development Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Oncolytic Virus Manufacturing and Development Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
